Pembrolizumab-based therapy in previously treated high grade extrapulmonary neuroendocrine carcinomas.
2018
TPS4147Background: The efficacy of
immune checkpointinhibitors (CPI) has not been established in extrapulmonary
high gradeneuroendocrine carcinomas (EP-HGNECs), a disease for which additional tre...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI